1585 related articles for article (PubMed ID: 28029207)
41. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
[TBL] [Abstract][Full Text] [Related]
42. The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome.
Kim WK; Möllmann H; Liebetrau C; Renker M; Rolf A; Simon P; Van Linden A; Arsalan M; Doss M; Hamm CW; Walther T
JACC Cardiovasc Interv; 2018 Sep; 11(17):1721-1729. PubMed ID: 29803694
[TBL] [Abstract][Full Text] [Related]
43. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.
Nijhoff F; Abawi M; Agostoni P; Ramjankhan FZ; Doevendans PA; Stella PR
Circ Cardiovasc Interv; 2015 Jun; 8(6):e002408. PubMed ID: 26033967
[TBL] [Abstract][Full Text] [Related]
44. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.
Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494
[TBL] [Abstract][Full Text] [Related]
45. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
[TBL] [Abstract][Full Text] [Related]
46. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
47. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
[TBL] [Abstract][Full Text] [Related]
48. Real-world comparison of the new 34 mm self-expandable transcatheter aortic prosthesis Evolut R to its 31 mm core valve predecessor.
Kalogeras K; Kabir T; Mittal T; Mirsadraee S; Skondras E; Rahman Haley S; Zuhair M; Vavuranakis M; Tousoulis D; Dalby M; Panoulas V
Catheter Cardiovasc Interv; 2019 Mar; 93(4):685-691. PubMed ID: 30280466
[TBL] [Abstract][Full Text] [Related]
49. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
[TBL] [Abstract][Full Text] [Related]
50. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.
Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877
[TBL] [Abstract][Full Text] [Related]
51. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
[TBL] [Abstract][Full Text] [Related]
52. Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI Registry.
Miyasaka M; Tada N; Taguri M; Kato S; Enta Y; Otomo T; Hata M; Watanabe Y; Naganuma T; Araki M; Yamanaka F; Shirai S; Ueno H; Mizutani K; Tabata M; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
JACC Cardiovasc Interv; 2018 Apr; 11(8):771-780. PubMed ID: 29673509
[TBL] [Abstract][Full Text] [Related]
53. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.
Regazzoli D; Chiarito M; Cannata F; Pagnesi M; Miura M; Ziviello F; Picci A; Reifart J; De Marco F; Bedogni F; Adamo M; Curello S; Teles R; Taramasso M; Barbanti M; Tamburino C; Stefanini GG; Mangieri A; Giannini F; Pagnotta PA; Maisano F; Kim WK; Van Mieghem NM; Colombo A; Reimers B; Latib A;
JACC Cardiovasc Interv; 2020 Jan; 13(2):196-206. PubMed ID: 31883714
[TBL] [Abstract][Full Text] [Related]
54. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.
Eitan A; Witt J; Stripling J; Haselbach T; Rieß FC; Schofer J
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1374-1379. PubMed ID: 29521464
[TBL] [Abstract][Full Text] [Related]
55. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
56. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
[TBL] [Abstract][Full Text] [Related]
57. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
Kolte D; Khera S; Vemulapalli S; Dai D; Heo S; Goldsweig AM; Aronow HD; Elmariah S; Inglessis I; Palacios IF; Thourani VH; Sharaf BL; Gordon PC; Abbott JD
JACC Cardiovasc Interv; 2018 Jun; 11(12):1175-1185. PubMed ID: 29929641
[TBL] [Abstract][Full Text] [Related]
58. Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement.
Stundl A; Schulte R; Lucht H; Weber M; Sedaghat A; Shamekhi J; Zur B; Grube E; Mellert F; Welz A; Fimmers R; Nickenig G; Werner N; Sinning JM
JACC Cardiovasc Interv; 2017 Aug; 10(15):1550-1560. PubMed ID: 28797433
[TBL] [Abstract][Full Text] [Related]
59. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
[TBL] [Abstract][Full Text] [Related]
60. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
Bandyopadhyay D; Sartori S; Baber U; Cao D; Chandiramani R; Tchétché D; Petronio AS; Mehilli J; Lefèvre T; Presbitero P; Capranzaro P; Sardella G; Van Mieghem NM; Chandrasekhar J; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Naber C; Kini A; Morice MC; Claessen BE; Chieffo A; Mehran R
Catheter Cardiovasc Interv; 2020 Jul; 96(1):198-207. PubMed ID: 31977142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
